Category: us corporate news

us corporate news

J.Jill Reports Fiscal 2025 Results: Declining Sales, Increased Dividend, and Fiscal 2026 Outlook with Tariff Impact

Minichart

March 31, 2026

J.Jill, Inc. Reports Q4 and Full-Year 2025 Results: Dividend...

Continue Reading 0

us corporate news

Immunic Appoints Biopharma Leader Jon Congleton to Board, Advancing MS Therapy Toward Phase 3 Pivotal Readouts

Minichart

March 31, 2026

Immunic, Inc. Bolsters Board of Directors with Appointment o...

Continue Reading 0

us corporate news

Skillsoft Appoints Cybersecurity CEO Art Gilliland to Board of Directors to Advance AI-Driven Workforce Transformation

Minichart

March 31, 2026

Skillsoft Corp. Appoints Art Gilliland to Board of Directors...

Continue Reading 0

us corporate news

Charlotte’s Web Announces BAT Debenture Conversion and $10M Equity Investment to Strengthen Balance Sheet

Minichart

March 31, 2026

Charlotte's Web Holdings Announces Major Transaction with BA...

Continue Reading 0

us corporate news

FactSet Reports 7% Revenue Growth and 6.7% Organic ASV Increase in Q2 2026 Financial Results

Minichart

March 31, 2026

FactSet Reports Q2 2026 Results: Key Takeaways for Investors...

Continue Reading 0

us corporate news

T1 Energy Reports Record 2025 Results, Advances U.S. Solar Manufacturing and Secures $160M Tax Credit Sale

Minichart

March 31, 2026

T1 Energy Reports Q4 and Full-Year 2025 Results: Strong Oper...

Continue Reading 0

us corporate news

Atlantic Union Bankshares to Release Q1 2026 Financial Results and Host Investor Call April 21, 2026

Minichart

March 31, 2026

Key Highlights First Quarter 2026 Financial Results Rel...

Continue Reading 0

us corporate news

Iterum Therapeutics plc Receives Nasdaq Delisting Notice – Form 8-K Filing Details and Company Information

Minichart

March 31, 2026

Iterum Therapeutics plc Announces Delisting from Nasdaq and ...

Continue Reading 0

us corporate news

Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) Targeting Advanced Triple-Negative Breast Cancer

Minichart

March 31, 2026

Telomir Pharmaceuticals, Inc. Submits IND for Telomir-1 (Tel...

Continue Reading 0

us corporate news

SCYNEXIS Acquires PXL-770 (SCY-770) to Advance Innovative ADPKD Therapy with Phase 2 Trial Planned for 2026

Minichart

March 31, 2026

SCYNEXIS Acquires PXL-770 (SCY-770) for ADPKD: Key Investor ...

Continue Reading 0